Abstract
The comparative efficacy and safety profiles of selected daily 1000 IU, weekly 7000 IU and monthly 30,000 IU vitamin D 3—not previously investigated—will be evaluated. Here, a prospective, randomized clinical trial, comparing efficacy and safety of a daily single dose of 1000 IU (group A) to a once-weekly 7000 IU dose (group B), or monthly 30,000 IU dose (group C) of vitamin D3. The present study is a controlled, randomized, open-label, multicenter clinical trial, 3 months in duration. Sixty-four adult subjects with vitamin D deficiency (25OHD<20 ng/ml), were included according to the inclusion and exclusion criteria. Dose-responses for increases in serum vitamin 25OHD were statistically equivalent for each of the three groups: A, B and C. Outcomes were 13.0 ± 1.5; 12.6 ± 1.1 and 12.9 ± 0.9 ng/ml increases in serum 25OHD per 1000 IU, daily, weekly and monthly, respectively. The treatment of subjects with selected doses restored 25OHD values to levels above 20 ng/ml in all groups. Treatment with distinct administration frequency of vitamin D3 did not exhibit any differences in safety parameters. The daily, weekly and monthly administrations of daily equivalent of 1000 IU of vitamin D3 provide equal efficacy and safety profiles.
Similar content being viewed by others
References
M.F. Holick, T.C. Chen, Vitamin D deficiency: a worldwide problem with health consequences. Am. J. Clin. Nutr. 87, 1080S–1086SS (2008)
A.C. Ross, J.E. Manson, S.A. Abrams, J.F. Aloia, P.M. Brannon, S.K. Clinton, R.A. Durazo-Arvizu, J.C. Gallagher, R.L. Gallo, G. Jones, C.S. Kovacs, S.T. Mayne, C.J. Rosen, S.A. Shapses, The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J. Clin. Endocrinol. Metab. 96, 53–58 (2011)
I. Takacs, I. Benko, E. Toldy, N. Wikonkál, L. Szekeres, E. Bodolay, E. Kiss, Z. Jambrik, B. Szabó, B. Merkely, Z. Valkusz, T. Kovács, A. Szabó, O. Grigoreff, Z. Nagy, J. Demeter, H.C. Horváth, N. Bittner, S. Várbíró, P. Lakatos, Hungarian consensus about the vitamin D effects on prevention and treatment of diseases. Orv. Hetil. 153(Suppl ), 5–26 (2012)
R. Vieth, P.C. Chan, G.D. MacFarlane, Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am. J. Clin. Nutr. 73, 288–294 (2001)
D.E. Lawson, J. Douglas, M. Lean, S. Sedrani, Estimation of vitamin D3 and 25-hydroxyvitamin D3 in muscle and adipose tissue of rats and man. Clin. Chim. Acta. 157, 175–181 (1986)
C. Gokce, O. Gokce, C. Baydinc, N. Ilhan, E. Alaşehirli, F. Ozküçük, M. Taşçi, M.K. Atilkeler, H. Celebi, N. Arslan, Use of random urine samples to estimate total urinary calcium and phosphate excretion. Arch. Intern. Med. 151, 1587–1588 (1991)
S. Ish-Shalom, E. Segal, T. Salganik, B. Raz, I.L. Bromberg, R.J. Vieth, Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. Clin. Endocrinol. Metab. 93(9), 3430–3435 (2008)
B. Szabó, Á.G. Tabák, E. Toldy, L. Szekeres, B. Szili, B. Bakos, B. Balla, J.P. Kósa, P. Lakatos, , I. Takács, The role of serum total and free 25-hydroxyvitamin D and PTH values in defining vitamin D status at the end of winter: a representative survey. J. Bone Miner. Metab. (2015) Dec 10. [Epub ahead of print].
V. Chel, H.A. Wijnhoven, J.H. Smit, M. Ooms, P. Lips, Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos. Int. 19(5), 663–671 (2008)
M.F. Holick, N.C. Binkley, H.A. Bischoff-Ferrari, C.M. Gordon, D.A. Hanley, R.P. Heaney, M.H. Murad, C.M. Weaver, Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab 96, 1911–1930 (2011)
A. Sorva, J. Risteli, L. Risteli, M. Valimaki, R. Tilvis, Effects of vitamin D and calcium on markers of bone metabolism in geriatric subjects with low serum 25-hydroxyvitamin D levels. Calcif. Tissue Int 49(Suppl, ), S88–S89 (1991)
R.P. Heaney, K.M. Davies, T.C. Chen, M.F. Holick, M.J. Barger-Lux, Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 77, 204–210 (2003)
A.M. Kenny, B. Biskup, B. Robbins, G. Marcella, J.A. Burleson, Effects of vitamin D supplementation on strength, physical function, and health perception in older, community-dwelling men. J. Am. Geriatr. Soc. 51, 1762–1767 (2003)
E.S. Orwoll, R.M. Weigel, S.K. Oviatt, M.R. McClung, L.J. Deftos, Calcium and cholecalciferol: effects of small supplements in normal men. Am. J. Clin. Nutr. 48, 127–130 (1988)
J. Pepe, I. Mezzaroma, A. Fantauzzi, M. Falciano, A. Salotti, M. Di Traglia, D. Diacinti, P. Biondi, C. Cipriani, M. Cilli, S. Minisola, An oral high dose of cholecalciferol restores vitamin D status in deficient postmenopausal HIV-1-infected women independently of protease inhibitors therapy: a pilot study. Endocrine 53, 299–304 (2016)
K.M. Sanders, A.L. Stuart, E.J. Williamson, J.A. Simpson, M.A. Kotowicz, D. Young, G.C. Nicholson, Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 303, 1815–1822 (2010)
M. Rossini, S. Adami, O. Viapiana, E. Fracassi, L. Idolazzi, M.R. Povino, D. Gatti, Dose-Dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers. Calcif. Tissue Int. 91, 365–369 (2012)
E.B. Mawer, K. Schaefer, G.A. Lumb, S.W. Stanbury, The metabolism of isotopically labelled vitamin D3 in man: the influence of the state of vitamin D nutrition. Clin Sci. 40, 39–53 (1971)
A. Shieh, R.F. Chun, C. Ma, S. Witzel, B. Meyer, B. Rafison, L. Swinkels, T. Huijis, S. Pepkowitz, B. Holmquist, M. Hewison, J.S. Adams, Effects of high-dose vitamin D2 versus D3 on total and free 25-Hydroxyvitamin D and markers of calcium balance. J. Clin. Endocrinol. Metab. 101, 3070–3078 (2016)
Acknowledgments
The authors are sincerely grateful to Stephanie C. Fox, J.D. of QueenBeeEdit of Bloomfield Connecticut, U.S.A. for her technical assistance in language improvement and proofreading of the manuscript. This work was supported by Pharma Patent KFT. There are no other organizations with any financial interest in the subject matter or material discussed in the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Béla E Tóth consulted for Pharma Patent KFT. Péter Lakatos and István Takács received lecture fees from Pharma Patent KFT. László Szekeres, Boglárka Szabó and Bence Bakos declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Takács, I., Tóth, B.E., Szekeres, L. et al. Randomized clinical trial to comparing efficacy of daily, weekly and monthly administration of vitamin D3 . Endocrine 55, 60–65 (2017). https://doi.org/10.1007/s12020-016-1137-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-016-1137-9